United States - English - NLM (National Library of Medicine)

zoetis inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sevoflo is indicated for induction and maintenance of general anesthesia in dogs. sevoflo is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

Ireland - English - HPRA (Health Products Regulatory Authority)

piramal critical care limited - sevoflurane - inhalation vapour, liquid - 100 percent volume/volume - halogenated hydrocarbons; sevoflurane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - sevoflurane 1 ml - inhalation vapour, liquid - 100 % - sevoflurane 1 ml/ml - sevoflurane

Kenya - English - Pharmacy and Poisons Board

piramal enterprises limited at: village bhatauli khurd, baddi – 173205, - sevoflurane - inhalation vapour - sevoflurane 250ml - general anesthetics: halogenatedhydrocarbons

United States - English - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sojourn ® (sevoflurane, usp) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sojourn ® (sevoflurane, usp) should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane, usp should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings - malignant hyperthermia,clinical pharmacology - pharmacogenomics ). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

United States - English - NLM (National Library of Medicine)

abbvie inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 250 ml in 250 ml - ultane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. ultane should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. - known or suspected genetic susceptibility to malignant hyperthermia (see warnings - malignant hyperthermia , clinical pharmacology - pharmacogenomics ). - known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

piramal enterprises limited - sevoflurane - liquid for inhalation - 100%

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أبوشيخة - abu sheikha drug store - sevoflurane 100 % - 100%

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - sevoflurane - liquid for inhalation - sevoflurane 100 % - sevoflurane - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

baxter healthcare corporation - sevoflurano - sevoflurano....100 %